Nifty
:
23408.80
Sensex
:
75502.85
257.70 (1.11%)
938.93 (1.26%)
Nifty
Sensex
:
:
23408.80
75502.85
257.70 (1.11%)
938.93 (1.26%)

Beta Drugs Ltd.

Pharmaceuticals & Drugs

Rating :
61/99

BSE: Not Listed | NSE: BETA

NSE BSE
1139.00
16-Mar-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1100
  •  1144.8
  •  1100
  •  1116.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  8364
  •  9460131.9
  •  2000
  •  990.1

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,154.59
  • 74.82
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,145.62
  • N/A
  • 8.72

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 64.90%
  • 8.54%
  • 21.78%
  • FII
  • DII
  • Others
  • 1.14%
  • 0.00%
  • 3.64%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.64
  • 25.56
  • 16.85

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 26.39
  • 24.70
  • 7.03

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 29.88
  • 29.34
  • 11.36

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 38.66
  • 40.23

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 8.67
  • 9.11

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 19.58
  • 22.05

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Net Sales
87.27
88.29
-1.16%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
70.28
69.84
0.63%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
16.99
18.45
-7.91%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
19.46%
20.90%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
2.31
0.97
138.14%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
4.43
1.88
135.64%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
4.39
3.24
35.49%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
10.47
11.96
-12.46%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
1.96
3.01
-34.88%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
8.52
8.95
-4.80%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
9.76%
10.13%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
8.40
8.86
-5.19%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Net Sales
-
362.36
295.71
227.11
183.84
116.12
90.81
65.93
50.57
Net Sales Growth
-
22.54%
30.21%
23.54%
58.32%
27.87%
37.74%
30.37%
 
Cost Of Goods Sold
-
171.36
149.41
105.69
94.46
58.78
44.36
33.43
27.18
Gross Profit
-
191.00
146.30
121.42
89.38
57.34
46.45
32.50
23.38
GP Margin
-
52.71%
49.47%
53.46%
48.62%
49.38%
51.15%
49.29%
46.23%
Total Expenditure
-
287.75
235.72
173.99
141.14
91.38
72.90
54.12
41.11
Power & Fuel Cost
-
5.29
4.48
3.43
2.80
2.36
1.67
0.95
0.76
% Of Sales
-
1.46%
1.51%
1.51%
1.52%
2.03%
1.84%
1.44%
1.50%
Employee Cost
-
26.86
20.14
17.08
12.10
8.32
6.95
3.80
1.26
% Of Sales
-
7.41%
6.81%
7.52%
6.58%
7.17%
7.65%
5.76%
2.49%
Manufacturing Exp.
-
35.52
27.33
20.42
14.48
10.41
8.33
6.93
5.46
% Of Sales
-
9.80%
9.24%
8.99%
7.88%
8.96%
9.17%
10.51%
10.80%
General & Admin Exp.
-
30.48
23.74
18.95
10.90
7.12
8.80
6.30
3.75
% Of Sales
-
8.41%
8.03%
8.34%
5.93%
6.13%
9.69%
9.56%
7.42%
Selling & Distn. Exp.
-
16.50
9.66
7.12
5.84
3.86
2.17
1.78
1.59
% Of Sales
-
4.55%
3.27%
3.14%
3.18%
3.32%
2.39%
2.70%
3.14%
Miscellaneous Exp.
-
1.74
0.95
1.29
0.56
0.53
0.64
0.93
1.11
% Of Sales
-
0.48%
0.32%
0.57%
0.30%
0.46%
0.70%
1.41%
2.19%
EBITDA
-
74.61
59.99
53.12
42.70
24.74
17.91
11.81
9.46
EBITDA Margin
-
20.59%
20.29%
23.39%
23.23%
21.31%
19.72%
17.91%
18.71%
Other Income
-
6.44
1.36
0.75
0.76
0.50
0.41
0.37
0.24
Interest
-
6.99
2.82
2.41
1.90
2.42
2.59
1.43
1.01
Depreciation
-
12.51
9.78
10.41
7.25
6.87
3.76
2.84
1.85
PBT
-
61.54
48.75
41.06
34.30
15.95
11.97
7.91
6.84
Tax
-
14.55
12.32
10.34
9.47
4.23
2.56
-0.13
0.07
Tax Rate
-
25.54%
25.27%
25.18%
27.61%
26.52%
21.39%
-1.64%
1.02%
PAT
-
42.42
36.44
30.72
24.83
11.72
9.42
8.04
6.76
PAT before Minority Interest
-
42.42
36.44
30.72
24.83
11.72
9.42
8.04
6.76
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
11.71%
12.32%
13.53%
13.51%
10.09%
10.37%
12.19%
13.37%
PAT Growth
-
16.41%
18.62%
23.72%
111.86%
24.42%
17.16%
18.93%
 
EPS
-
42.00
36.08
30.42
24.58
11.60
9.33
7.96
6.69

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Shareholder's Funds
197.10
157.12
122.88
92.34
68.61
57.11
40.92
32.88
Share Capital
10.09
9.61
9.61
9.61
9.61
9.61
8.65
8.65
Total Reserves
187.00
147.50
113.27
82.73
59.00
47.50
32.27
24.23
Non-Current Liabilities
134.58
10.90
11.32
15.86
14.95
13.21
9.07
3.15
Secured Loans
9.99
6.04
6.97
11.83
11.13
10.28
6.90
2.34
Unsecured Loans
117.00
0.00
0.00
0.00
0.00
0.00
0.04
0.41
Long Term Provisions
2.56
2.18
1.83
1.47
1.14
0.79
0.42
0.00
Current Liabilities
113.39
94.40
69.70
54.85
36.59
37.99
33.36
13.55
Trade Payables
71.25
59.27
40.24
31.95
20.49
14.49
13.12
6.11
Other Current Liabilities
21.46
17.64
9.54
8.63
7.84
11.35
7.68
3.53
Short Term Borrowings
5.71
4.96
9.07
4.75
3.54
9.65
10.88
3.59
Short Term Provisions
14.97
12.53
10.86
9.51
4.71
2.51
1.69
0.33
Total Liabilities
445.07
262.42
203.90
163.05
120.15
108.31
83.35
49.58
Net Block
88.93
64.59
62.76
54.95
39.97
43.82
17.67
13.19
Gross Block
146.30
109.49
99.37
82.17
61.14
58.29
25.38
18.06
Accumulated Depreciation
57.37
44.90
36.61
27.22
21.17
14.46
7.71
4.87
Non Current Assets
103.33
74.82
69.54
60.21
48.82
50.97
39.45
17.26
Capital Work in Progress
0.00
0.00
0.00
0.00
2.81
0.08
14.69
1.35
Non Current Investment
0.00
0.00
0.78
0.78
0.78
0.35
0.35
0.00
Long Term Loans & Adv.
14.14
10.17
5.95
4.43
4.31
5.60
5.62
2.72
Other Non Current Assets
0.26
0.06
0.05
0.05
0.95
1.12
1.12
0.00
Current Assets
341.73
187.60
134.37
102.83
71.33
57.34
43.91
32.32
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
59.77
49.81
30.62
22.48
16.04
12.35
9.53
2.80
Sundry Debtors
102.58
79.24
62.72
45.18
33.88
31.93
25.03
14.44
Cash & Bank
147.02
28.63
19.16
17.32
10.42
5.39
3.30
11.91
Other Current Assets
32.36
0.52
0.91
0.32
10.98
7.69
6.05
3.17
Short Term Loans & Adv.
30.66
29.39
20.96
17.53
5.73
3.23
2.54
1.87
Net Current Assets
228.35
93.20
64.67
47.99
34.74
19.35
10.55
18.78
Total Assets
445.06
262.42
203.91
163.04
120.15
108.31
83.36
49.58

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Cash From Operating Activity
36.14
30.93
23.38
29.63
18.60
8.41
0.11
17.10
PBT
61.54
48.75
41.06
34.30
15.95
11.97
7.91
6.84
Adjustment
-6.37
-4.25
2.02
5.10
6.54
2.40
1.64
15.06
Changes in Working Capital
-19.03
-13.58
-19.69
-9.77
-3.89
-5.96
-9.43
-4.79
Cash after chg. in Working capital
36.14
30.93
23.38
29.63
18.60
8.41
0.11
17.10
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-35.72
-13.97
-19.07
-21.75
-5.85
-15.05
-20.78
-10.79
Net Fixed Assets
-24.40
-5.28
-5.98
-8.81
-3.43
-7.52
-14.69
Net Investments
0.00
0.78
-0.01
0.00
-0.42
-4.51
-1.61
Others
-11.32
-9.47
-13.08
-12.94
-2.00
-3.02
-4.48
Cash from Financing Activity
117.97
-7.49
-2.47
-0.97
-7.71
8.73
12.07
5.45
Net Cash Inflow / Outflow
118.39
9.47
1.84
6.90
5.04
2.09
-8.61
11.76
Opening Cash & Equivalents
28.63
19.16
17.32
10.42
5.39
3.30
11.91
0.14
Closing Cash & Equivalent
147.02
28.63
19.16
17.32
10.42
5.39
3.30
11.91

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Book Value (Rs.)
195.25
155.65
127.82
96.05
71.37
59.41
47.31
38.02
ROA
11.99%
15.63%
16.74%
17.53%
10.26%
9.82%
12.10%
13.64%
ROE
23.95%
26.03%
28.55%
30.85%
18.65%
19.21%
21.79%
20.57%
ROCE
25.23%
32.74%
33.94%
36.38%
22.17%
20.71%
18.41%
19.36%
Fixed Asset Turnover
2.83
2.83
2.50
2.57
1.94
2.17
3.04
2.80
Receivable days
91.57
87.61
86.71
78.48
103.42
114.47
109.26
104.25
Inventory Days
55.19
49.64
42.67
38.24
44.62
43.97
34.14
20.24
Payable days
139.01
121.55
124.66
101.32
108.61
71.61
67.09
57.25
Cash Conversion Cycle
7.75
15.70
4.72
15.40
39.42
86.83
76.30
67.23
Total Debt/Equity
0.70
0.09
0.17
0.22
0.25
0.40
0.49
0.23
Interest Cover
9.15
18.29
18.00
19.06
7.59
5.63
6.52
7.74

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Beta Drugs - Quarterly Results
    15th Feb 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.